Schuchardt · Prostaglandins, leukotrienes, and essential fatty acids 2024 · Uncontrolled before-and-after trial · n=31

Omega-3 supplementation changes the physical properties of leukocytes but not erythrocytes in healthy individuals: An exploratory trial.

Cited 5 times in the scientific literature.

Level 4 - case-series / case-control

Uncontrolled before-and-after exploratory trial with no concurrent control group.

PubMed 39159530 · doi:10.1016/j.plefa.2024.102636 · record verified 2026-08-27

What was done

Thirty-one healthy participants received 12 weeks of daily fish-oil supplementation providing 1500 mg of combined EPA and DHA. Researchers measured the Omega-3 Index (percentage of EPA+DHA in red blood cells) and evaluated the deformability of multiple blood cell types using deformability cytometry (DC) for all cell types and Laser-assisted Optical Rotational Red Cell Analysis (Lorrca) specifically for red blood cells.

What was found

Mean ± SD Omega-3 Index increased significantly from 5.3% ± 1.5% to 8.3% ± 1.4% (p < 0.001). No significant changes in red blood cell deformability were found with either DC or Lorrca. In contrast, DC demonstrated significant increases in deformability metrics in lymphocytes, neutrophils, and monocytes (resulting in less stiff cells); exact numerical values and effect sizes for leukocyte deformability metrics were not reported in the abstract.

Why it matters

This study provides evidence that dietary omega-3 fatty acids alter the physical flexibility of human immune cells, offering a potential mechanical mechanism for their circulatory and anti-inflammatory properties.

Limits

The study is limited by a small sample size (n = 31), an uncontrolled design without a placebo comparator, and a healthy population. Deformability metrics for leukocytes were not reported with exact numbers in the abstract, and functional immunological or clinical outcomes were not directly evaluated.

Cited by